Skylark Bio
Pre-clinicalDevelops gene therapies for genetic disorders using novel viral vector and delivery technologies.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $60M
About
Develops gene therapies for genetic disorders using novel viral vector and delivery technologies.
RNA & Gene Therapy
Funding History
2Total raised:$60M
Series A$45MJul 15, 2022
Seed$15MMar 15, 2021